Longitude Rx Appoints Inaugural Chief Commercial Officer

Stacy Walton to lead growth and market expansion for health system-owned specialty pharmacy services organization.

Mar. 31, 2026 at 10:20pm

Got story updates? Submit your updates here. ›

Longitude Rx, a health system-owned specialty pharmacy services organization, has announced the appointment of Stacy Walton as its inaugural Chief Commercial Officer (CCO). Walton brings extensive experience in the specialty pharmacy industry to drive Longitude Rx's growth and market expansion.

Why it matters

The appointment of a seasoned CCO signals Longitude Rx's commitment to strengthening its position in the competitive specialty pharmacy market and expanding its reach to serve more health systems and patients.

The details

In her new role, Walton will be responsible for leading Longitude Rx's commercial strategy, including sales, marketing, and business development initiatives. Her expertise in the specialty pharmacy industry is expected to help the organization capitalize on emerging opportunities and better serve its health system partners.

  • Longitude Rx announced Walton's appointment on March 31, 2026.

The players

Longitude Rx

A health system-owned specialty pharmacy services organization.

Stacy Walton

Longitude Rx's inaugural Chief Commercial Officer, bringing extensive experience in the specialty pharmacy industry.

Got photos? Submit your photos here. ›

The takeaway

Longitude Rx's appointment of a seasoned CCO underscores the organization's focus on growth and market expansion, as it seeks to leverage its health system partnerships and expertise to better serve patients in the specialty pharmacy space.